Gastrointestinal Cancer

These guidelines and other documents provide advice for different types of gastrointestinal cancer: colorectal, pancreas, gastric/stomach, rectal, small bowel and appendix, anus, esophagus, hepatobiliary, liver and bile duct.

Displaying Guidelines

65 articles

Systemic therapy for unresectable advanced or metastatic pancreatic and midgut neuroendocrine tumours

Document Status: Current
ID: GL 2-21
Version: 2

Updated

Mar 2024

The Role of Bevacizumab (Avastin®) Combined with Chemotherapy in the Treatment of Patients with Advanced Colorectal Cancer

Document Status: Archived
ID: 2-25

Dec 2013

The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer

Document Status: Archived
ID: CED 1

Jun 2005

The Role of IMRT in Gastrointestinal Cancer

Document Status: Archived
ID: 21-3-10

Oct 2010

The Role of Oxaliplatin Combined with 5-Fluorouracil and Folinic Acid in the First and Second-line Treatment of Advanced Colorectal Cancer

Document Status: Archived
ID: 2-22

Sep 2011

The Role of Porfimer Sodium (PhotofrinTM) in the Ablation of High-Grade Dysplasia in Barrett's Esophagus

Document Status: Archived
ID: CED 2
Version: 2

Jan 2006

The Role of Porfimer Sodium (PhotofrinTM) in the Palliative Treatment of Esophageal Cancer

Document Status: Archived
ID: CED 3

Jan 2006

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Document Status: Current
ID: GL END 2-31

Jul 2018

The Treatment of Locally Advanced Pancreatic Cancer

Document Status: Archived
ID: 2-7
Version: 2

Jan 2016

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Document Status: Archived
ID: CED 8

Jul 2008

The Use of FOLFIRINOX as First-Line Treatment for Metastatic Pancreatic Adenocarcinoma

Document Status: Archived
ID: 2-18

Jun 2011

The Use of Leucovorin in Colorectal Cancer

Document Status: Archived
ID: 12-17

Feb 2016